PropertyValue
?:abstract
  • Metabolic diseases emerged as important risk factors for severe COVID-19, but the mechanisms responsible remained unclear for some time. The severity of metabolic diseases was also associated with worse outcomes in patients with COVID-19, forcing clinicians to adjust their thinking on which patients with metabolic disease, but without COVID-19, to prioritize for treatment during and immediately after the pandemic.
?:creator
?:doi
?:doi
  • 10.1038/s41574-020-00449-y
?:journal
  • Nat_Rev_Endocrinol
?:license
  • no-cc
?:pdf_json_files
  • document_parses/pdf_json/ce436147f71aa28fb8a0b1df3a0ec98d661578ac.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7687210.xml.json
?:pmcid
?:pmid
?:pmid
  • 33239662.0
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:sha_id
?:source
  • Medline; PMC
?:title
  • COVID-19 alters thinking and management in metabolic diseases
?:type
?:year
  • 2020-11-25

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/o92af6ch>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/o92af6ch>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all